Cadila Pharmaceuticals to invest about 500 Crores in Udaipur

Cadila Pharmaceuticals is one of the largest privately held pharmaceutical companies in India. Headquartered at Ahmedabad, it caters to over 45 therapeutic areas, with presence in over 90 countries.

The news has already caught up attraction in many eyes that the renowned pharma giant has made up its plans to enter the city of lakes for establishing a new medicinal plant. The State Cabinet meeting, headed by the Chief Minister Mr. Ashok Gehlot has sanctioned approval to the company for establishing an Active Pharmaceuticals Ingredients (API) and Manufacturing Unit in Udaipur. The Company will be investing Rs.130 crores in our Udaipur and will be giving employment opportunity to over 850 people. It is noteworthy that this investment might increase to Rs.500 crores in the second phase of the project. The project will prove fruitful for all the Udaipies as far as the employment is concerned. According to the sources the company will be provided a realisation on Entry tax on an approved list of some of its capital goods. As per the decision the company will also be given a 5% planning grant and 70% directive grant so that the project turns out to be a success.

According to a local newspaper, the Cabinet has approved investments valued over Rs. 8800 crores for the state of Rajasthan. The plant will be established in RIICO industrial area, Kaladwas where 30 acres of land has been reserved for the same.